HOV Q1 2026 Earnings EPS Surprise Beats Expectations Amid Challenging Housing Market NKE Q1 2026 Earnings EPS Surprises 2289 Above Estimates as Stock Gains ROST Q1 2026 Earnings EPS Beats Estimates by 145 Amid Cautious Consumer Environment Inhibikase Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss but Stock Declines UTSI Q4 2019 Earnings Significant EPS Miss Highlights Operational Challenges Contineum Therapeutics Inc CTNM Q1 2026 Earnings ClinicalStage Biotech Reports Narrower Loss Shares Dip